Mednax
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $487,783 | $476,196 | $493,771 | $492,875 |
Gross Profit | 132,470 | 112,964 | 120,353 | 140,349 |
EBITDA | 57,454 | 53,228 | 59,966 | 96,387 |
EBIT | 51,672 | 47,109 | 54,335 | 90,836 |
Net Income | 39,843 | 29,572 | 33,683 | 71,708 |
Net Change In Cash | 487,783 | 476,196 | 493,771 | 492,875 |
Free Cash Flow | 123,944 | -135,749 | 108,815 | 131,947 |
Cash | 288,879 | 205,780 | 375,241 | 340,059 |
Basic Shares | 81,412 | 83,075 | 84,415 | 85,613 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,913,849 | $2,012,919 | $1,994,640 | $1,972,021 |
Gross Profit | 471,876 | 454,344 | 421,565 | 467,033 |
EBITDA | 274,224 | -28,372 | 29,887 | 156,701 |
EBIT | 252,397 | -60,598 | -6,284 | 121,065 |
Net Income | 165,388 | -99,069 | -60,408 | 66,335 |
Net Change In Cash | 1,913,849 | 2,012,919 | 1,994,640 | 1,972,021 |
Cost of Revenue | -377,567 | |||
Free Cash Flow | 252,633 | 184,551 | 103,997 | 137,233 |
Cash | 375,241 | 229,940 | 73,258 | 9,824 |
Basic Shares | 85,268 | 83,330 | 82,201 | 84,121 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.58 |
2026-03-31 | $0.44 |
2025-12-31 | $0.50 |
2025-09-30 | $0.67 |